According to the research report titled ‘Global Neurorehabilitation Device Market 2019-2028’, available with Market Study Report, global neurorehabilitation device market is projected to register a y-o-y growth rate of 14.52% during 2019-2028.
 

Increasing incidence of neurological diseases is a major factor driving the growth of global neurorehabilitation device market. Additionally, rising geriatric populace, growing adoption of neurorehabilitation wearables & robotics, along with technological advancements are further generating lucrative prospects for the business scenario.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552546/
 

On the downside, lack of medical professionals to treat people with neurological diseases, and high costs of treatment are restraining the market progression. Moreover, strict government regulations is hampering the growth rate of the industry.
 

Based on product type, worldwide neurorehabilitation device industry is segmented into neuro-robotic system, wearable device, brain-computer interface, non-invasive stimulator, and other products. Speaking of application range, the marketplace is divided into stroke, Parkinson’s disease, cerebral palsy, multiple sclerosis, and others. Moving on to end user spectrum, the business sphere is categorized into hospital/clinic, cognitive care center, and research institute including others.
 

Considering the geographical analysis, neurorehabilitation device industry trends are scrutinized across North America, Latin America, Middle East & Africa, Europe, and Asia-Pacific.
 

Expert analysts cite that Asia-Pacific market is likely to display robust growth patterns over the forecast period, owing to increasing geriatric populace in the region and prevalence of neurological diseases in this age group. Moreover, initiatives by government & private organizations to spread awareness about neurological conditions, along with their assistance to help such patients to lead normal lives are positively swaying the industry dynamics in APAC.
 

Leading players in worldwide neurorehabilitation device industry are Reha Technology AG, Biometrics Ltd., Abbott Laboratories, Kinova, Ectron Limited, BioXtreme, Tyromotion GmbH, Bionik Laboratories Corp., Ekso Bionics Holdings Inc., NeuroStyle Pte Ltd., Saebo Inc., Kinestica, Hocoma AG, Helius Medical Technologies Inc., and Medtronic plc.